HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.

Also called NCT02608632

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 170 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02608632
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02608632. Randomized; double masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure
Condition
Hypertension
Intervention (Device)
Renal denervation guided by HFS
Intervention (Device)
Renal denervation as standard procedure
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation (class: research network)

Record details

Record id
cardio:ct-nct02608632
Content hash
3da229471dc74fecdf04c977fbbf35e02bb6afe6c67483fba3ab6a21cd4eb73f